A total of 44 patients with metastatic colorectal cancer received modified FOLFOX6 or FOLFOX4 as first-line chemotherapy between July 2006 and November 2008 at three institutions.
A total of 44 patients with metastatic colorectal cancer received modified FOLFOX6 or FOLFOX4 as first-line chemotherapy between July 2006 and November 2008 at three institutions.